New Risk • May 05
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. Cash payout ratio: 186% Dividend yield: 0.9% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company. Reported Earnings • Apr 28
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: CN¥2.16 (up from CN¥1.86 in FY 2024). Revenue: CN¥6.02b (up 5.9% from FY 2024). Net income: CN¥496.6m (up 17% from FY 2024). Profit margin: 8.2% (up from 7.5% in FY 2024). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 4.9%. Earnings per share (EPS) also missed analyst estimates by 6.2%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 4% per year. Tillkännagivande • Apr 28
Rianlon Corporation, Annual General Meeting, May 25, 2026 Rianlon Corporation, Annual General Meeting, May 25, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Tianjin China Tillkännagivande • Mar 31
Rianlon Corporation to Report Q1, 2026 Results on Apr 28, 2026 Rianlon Corporation announced that they will report Q1, 2026 results on Apr 28, 2026 Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥39.45, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 23x in the Chemicals industry in China. Total loss to shareholders of 12% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥37.48 per share. Buy Or Sell Opportunity • Jan 06
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 11% to CN¥43.38. The fair value is estimated to be CN¥35.60, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.2% over the last 3 years. Earnings per share has declined by 6.3%. Revenue is forecast to grow by 35% in 2 years. Earnings are forecast to grow by 40% in the next 2 years. Tillkännagivande • Dec 31
Rianlon Corporation to Report Fiscal Year 2025 Results on Apr 28, 2026 Rianlon Corporation announced that they will report fiscal year 2025 results on Apr 28, 2026 Buy Or Sell Opportunity • Dec 03
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 28% to CN¥43.11. The fair value is estimated to be CN¥35.28, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.2% over the last 3 years. Earnings per share has declined by 6.3%. Revenue is forecast to grow by 35% in 2 years. Earnings are forecast to grow by 37% in the next 2 years. Buy Or Sell Opportunity • Nov 03
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 25% to CN¥41.18. The fair value is estimated to be CN¥34.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.2% over the last 3 years. Earnings per share has declined by 6.3%. Revenue is forecast to grow by 34% in 2 years. Earnings are forecast to grow by 36% in the next 2 years. Reported Earnings • Oct 22
Third quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind Third quarter 2025 results: EPS: CN¥0.66 (up from CN¥0.41 in 3Q 2024). Revenue: CN¥1.51b (up 4.8% from 3Q 2024). Net income: CN¥150.9m (up 61% from 3Q 2024). Profit margin: 10.0% (up from 6.5% in 3Q 2024). Revenue missed analyst estimates by 4.8%. Earnings per share (EPS) exceeded analyst estimates by 40%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 15% per year, which means it is performing significantly worse than earnings. Tillkännagivande • Sep 30
Rianlon Corporation to Report Q3, 2025 Results on Oct 21, 2025 Rianlon Corporation announced that they will report Q3, 2025 results on Oct 21, 2025 Price Target Changed • Sep 01
Price target increased by 11% to CN¥38.07 Up from CN¥34.32, the current price target is an average from 5 analysts. New target price is 5.4% above last closing price of CN¥36.10. Stock is up 46% over the past year. The company is forecast to post earnings per share of CN¥2.19 for next year compared to CN¥1.86 last year. Tillkännagivande • Jul 02
Rianlon Corporation to Report First Half, 2025 Results on Aug 28, 2025 Rianlon Corporation announced that they will report first half, 2025 results on Aug 28, 2025 Tillkännagivande • May 22
Rianlon Corporation Approves Dividend for 2024 Rianlon Corporation its Annual General Meeting of 2024 on 16 May 2025, during which the following proposal(s) was/were approved: Cash dividend per 10 shares (tax included): CNY 3.70000000. Tillkännagivande • Apr 23
Rianlon Corporation Proposes Final Cash Dividend for 2024 Rianlon Corporation proposed final cash dividend of CNY 3.70000000 per 10 shares (tax included) for 2024. Reported Earnings • Apr 22
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: CN¥1.86 (up from CN¥1.58 in FY 2023). Revenue: CN¥5.69b (up 7.7% from FY 2023). Net income: CN¥426.3m (up 18% from FY 2023). Profit margin: 7.5% (up from 6.9% in FY 2023). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 6.0%. Earnings per share (EPS) also missed analyst estimates by 6.5%. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 10% per year. Tillkännagivande • Apr 22
Rianlon Corporation, Annual General Meeting, May 16, 2025 Rianlon Corporation, Annual General Meeting, May 16, 2025, at 15:00 China Standard Time. Location: The Company's Meeting Room, Tianjin China Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to CN¥24.69, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 47% over the past three years. Tillkännagivande • Mar 31
Rianlon Corporation to Report Q1, 2025 Results on Apr 29, 2025 Rianlon Corporation announced that they will report Q1, 2025 results on Apr 29, 2025 Tillkännagivande • Dec 31
Rianlon Corporation to Report Fiscal Year 2024 Results on Apr 22, 2025 Rianlon Corporation announced that they will report fiscal year 2024 results on Apr 22, 2025 Reported Earnings • Oct 29
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: EPS: CN¥0.41 (down from CN¥0.44 in 3Q 2023). Revenue: CN¥1.45b (up 6.9% from 3Q 2023). Net income: CN¥93.8m (down 6.5% from 3Q 2023). Profit margin: 6.5% (down from 7.4% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 7.0%. Earnings per share (EPS) also missed analyst estimates by 11%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 11% per year. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥28.12, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 28% over the past three years. New Risk • Sep 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.0% average weekly change). Tillkännagivande • Sep 30
Rianlon Corporation to Report Q3, 2024 Results on Oct 29, 2024 Rianlon Corporation announced that they will report Q3, 2024 results on Oct 29, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to CN¥26.77, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 25% over the past three years. Price Target Changed • Sep 06
Price target decreased by 7.6% to CN¥35.69 Down from CN¥38.62, the current price target is an average from 5 analysts. New target price is 49% above last closing price of CN¥23.90. Stock is down 31% over the past year. The company is forecast to post earnings per share of CN¥2.02 for next year compared to CN¥1.58 last year. Reported Earnings • Aug 26
Second quarter 2024 earnings: EPS and revenues miss analyst expectations Second quarter 2024 results: EPS: CN¥0.49 (up from CN¥0.43 in 2Q 2023). Revenue: CN¥1.47b (up 11% from 2Q 2023). Net income: CN¥113.0m (up 13% from 2Q 2023). Profit margin: 7.7% (up from 7.6% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 7.4%. Earnings per share (EPS) also missed analyst estimates by 3.5%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings. Tillkännagivande • Jun 29
Rianlon Corporation to Report First Half, 2024 Results on Aug 26, 2024 Rianlon Corporation announced that they will report first half, 2024 results on Aug 26, 2024 Declared Dividend • Jun 27
Dividend of CN¥0.34 announced Dividend of CN¥0.34 is the same as last year. Ex-date: 2nd July 2024 Payment date: 2nd July 2024 Dividend yield will be 1.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (20% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 26% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 86% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Tillkännagivande • Jun 26
Rianlon Corporation Announces Final Dividend of A Shares for 2023, Payable on July 2, 2024 Rianlon Corporation announced final cash dividend of CNY 3.44000000 per 10 A shares for 2023. Record date: 01 July 2024. Ex-date: 02 July 2024. Payment date: 02 July 2024. Reported Earnings • Apr 27
First quarter 2024 earnings released: EPS: CN¥0.47 (vs CN¥0.36 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.47 (up from CN¥0.36 in 1Q 2023). Revenue: CN¥1.35b (up 14% from 1Q 2023). Net income: CN¥107.1m (up 29% from 1Q 2023). Profit margin: 7.9% (up from 7.0% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Apr 24
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥27.12, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 30% over the past three years. Tillkännagivande • Apr 19
Rianlon Corporation, Annual General Meeting, May 13, 2024 Rianlon Corporation, Annual General Meeting, May 13, 2024, at 15:00 China Standard Time. Location: The Company's Meeting Room, Tianjin China Reported Earnings • Apr 18
Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2023 results: EPS: CN¥1.58 (down from CN¥2.40 in FY 2022). Revenue: CN¥5.28b (up 9.0% from FY 2022). Net income: CN¥362.5m (down 31% from FY 2022). Profit margin: 6.9% (down from 11% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 5.7%. Earnings per share (EPS) missed analyst estimates by 7.9%. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Tillkännagivande • Mar 30
Rianlon Corporation to Report Q1, 2024 Results on Apr 27, 2024 Rianlon Corporation announced that they will report Q1, 2024 results on Apr 27, 2024 New Risk • Feb 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.3% average weekly change). Profit margins are more than 30% lower than last year (7.3% net profit margin). Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥20.32, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years. Tillkännagivande • Dec 29
Rianlon Corporation to Report Fiscal Year 2023 Results on Apr 18, 2024 Rianlon Corporation announced that they will report fiscal year 2023 results on Apr 18, 2024 Price Target Changed • Dec 26
Price target decreased by 7.6% to CN¥41.20 Down from CN¥44.57, the current price target is an average from 5 analysts. New target price is 50% above last closing price of CN¥27.43. Stock is down 46% over the past year. The company is forecast to post earnings per share of CN¥1.71 for next year compared to CN¥2.40 last year. Reported Earnings • Oct 24
Third quarter 2023 earnings: EPS and revenues exceed analyst expectations Third quarter 2023 results: EPS: CN¥0.44 (down from CN¥0.70 in 3Q 2022). Revenue: CN¥1.35b (up 1.9% from 3Q 2022). Net income: CN¥100.3m (down 38% from 3Q 2022). Profit margin: 7.4% (down from 12% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) also surpassed analyst estimates by 6.6%. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Tillkännagivande • Sep 30
Rianlon Corporation to Report Q3, 2023 Results on Oct 24, 2023 Rianlon Corporation announced that they will report Q3, 2023 results on Oct 24, 2023 Board Change • Sep 28
Less than half of directors are independent Following the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Non-Independent Director Borui Han was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Major Estimate Revision • Aug 31
Consensus revenue estimates fall by 14% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥5.74b to CN¥4.94b. EPS estimate fell from CN¥2.55 to CN¥1.83 per share. Net income forecast to grow 27% next year vs 63% growth forecast for Chemicals industry in China. Consensus price target down from CN¥55.60 to CN¥49.57. Share price rose 5.2% to CN¥34.69 over the past week. Price Target Changed • Aug 30
Price target decreased by 11% to CN¥49.57 Down from CN¥55.60, the current price target is an average from 3 analysts. New target price is 43% above last closing price of CN¥34.55. Stock is down 34% over the past year. The company is forecast to post earnings per share of CN¥1.61 for next year compared to CN¥2.40 last year. New Risk • Aug 25
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 8.5% Last year net profit margin: 12% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (173% cash payout ratio). Profit margins are more than 30% lower than last year (8.5% net profit margin). Price Target Changed • Aug 16
Price target decreased by 9.7% to CN¥55.60 Down from CN¥61.60, the current price target is an average from 3 analysts. New target price is 50% above last closing price of CN¥37.19. Stock is down 21% over the past year. The company is forecast to post earnings per share of CN¥2.55 for next year compared to CN¥2.40 last year. Tillkännagivande • Jul 01
Rianlon Corporation to Report First Half, 2023 Results on Aug 25, 2023 Rianlon Corporation announced that they will report first half, 2023 results on Aug 25, 2023 Tillkännagivande • Jun 15
Rianlon Corporation Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 21, 2023 Rianlon Corporation announced final cash dividend of CNY 3.44 per 10 shares on A shares for the year 2022. Record date is June 20, 2023, Ex-Date is June 21, 2023 and Payment Date is June 21, 2023. Price Target Changed • Apr 12
Price target decreased by 8.3% to CN¥68.67 Down from CN¥74.89, the current price target is an average from 3 analysts. New target price is 62% above last closing price of CN¥42.38. Stock is down 7.3% over the past year. The company is forecast to post earnings per share of CN¥3.34 for next year compared to CN¥2.40 last year. Reported Earnings • Apr 08
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: CN¥2.40 (up from CN¥2.04 in FY 2021). Revenue: CN¥4.84b (up 41% from FY 2021). Net income: CN¥525.7m (up 26% from FY 2021). Profit margin: 11% (down from 12% in FY 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.0%. Earnings per share (EPS) also missed analyst estimates by 9.3%. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Price Target Changed • Nov 16
Price target increased to CN¥80.25 Up from CN¥74.89, the current price target is an average from 2 analysts. New target price is 35% above last closing price of CN¥59.23. Stock is up 42% over the past year. The company is forecast to post earnings per share of CN¥2.60 for next year compared to CN¥2.04 last year. Price Target Changed • Oct 26
Price target increased to CN¥80.25 Up from CN¥74.89, the current price target is an average from 2 analysts. New target price is 26% above last closing price of CN¥63.50. Stock is up 59% over the past year. The company is forecast to post earnings per share of CN¥2.60 for next year compared to CN¥2.04 last year. Reported Earnings • Oct 25
Third quarter 2022 earnings released: EPS: CN¥0.70 (vs CN¥0.55 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.70 (up from CN¥0.55 in 3Q 2021). Revenue: CN¥1.33b (up 46% from 3Q 2021). Net income: CN¥160.7m (up 42% from 3Q 2021). Profit margin: 12% (in line with 3Q 2021). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 24% per year whereas the company’s share price has increased by 19% per year. Price Target Changed • Oct 08
Price target increased to CN¥73.64 Up from CN¥63.03, the current price target is an average from 2 analysts. New target price is 34% above last closing price of CN¥54.77. Stock is up 50% over the past year. The company is forecast to post earnings per share of CN¥2.44 for next year compared to CN¥2.04 last year. Reported Earnings • Aug 24
Second quarter 2022 earnings released: EPS: CN¥0.70 (vs CN¥0.47 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.70 (up from CN¥0.47 in 2Q 2021). Revenue: CN¥1.26b (up 58% from 2Q 2021). Net income: CN¥148.1m (up 54% from 2Q 2021). Profit margin: 12% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 26%, compared to a 42% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 17% per year. Tillkännagivande • Jul 15
Rianlon Corporation Approves Management Appointments Rianlon Corporation at its Extraordinary General Meeting held on 13 July 2022, approved election of Han Borui as non-independent director; election of Wei Lixing and He Yongjun as independent directors; and election of Ye Qiang as shareholder supervisor. Valuation Update With 7 Day Price Move • May 03
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥45.88, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 44% over the past three years. Reported Earnings • Apr 28
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: EPS: CN¥0.62 (up from CN¥0.44 in 1Q 2021). Revenue: CN¥1.01b (up 23% from 1Q 2021). Net income: CN¥126.2m (up 40% from 1Q 2021). Profit margin: 13% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.5%. Earnings per share (EPS) also surpassed analyst estimates by 4.3%. Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 1 highly experienced director. 3 independent directors (6 non-independent directors). Independent Director Wei Man Hou was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Tillkännagivande • Apr 08
Rianlon Corporation Announces the Implementation of Final Cash Dividend for 2021, Payable on 14 April 2022 Rianlon Corporation announced the implementation of a final cash dividend of CNY 3.06000000 per 10 A shares (tax included) for 2021. Record date is 13 April 2022 with Ex-date on 14 April 2022 and Payment date on 14 April 2022. Price Target Changed • Mar 03
Price target increased to CN¥51.00 Up from CN¥44.67, the current price target is an average from 3 analysts. New target price is 10% above last closing price of CN¥46.28. Stock is up 34% over the past year. The company is forecast to post earnings per share of CN¥2.56 for next year compared to CN¥2.04 last year. Tillkännagivande • Mar 03
Rianlon Corporation, Annual General Meeting, Mar 21, 2022 Rianlon Corporation, Annual General Meeting, Mar 21, 2022, at 15:00 China Standard Time. Agenda: To consider 2021 work report of the board of directors; to consider 2021 annual report and its summary; to consider 2021 annual accounts; to consider 2021 profit distribution plan; to consider 2022 application for bank credit line; to consider 2021 work report of the supervisory committee; to consider 2022 remuneration (allowance) for supervisors; and to consider any other matters. Tillkännagivande • Mar 01
Rianlon Corporation Proposes Cash Dividend for the Year 2021 Rianlon Corporation proposed cash dividend/10 shares (tax included) of CNY 3.06000000 for the year 2021. Reported Earnings • Mar 01
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: CN¥2.04 (up from CN¥1.43 in FY 2020). Revenue: CN¥3.44b (up 39% from FY 2020). Net income: CN¥417.6m (up 43% from FY 2020). Profit margin: 12% (in line with FY 2020). Revenue exceeded analyst estimates by 7.8%. Earnings per share (EPS) also surpassed analyst estimates by 4.3%. Over the next year, revenue is forecast to grow 19%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 13% per year. Reported Earnings • Oct 26
Third quarter 2021 earnings released: EPS CN¥0.55 (vs CN¥0.38 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥908.7m (up 52% from 3Q 2020). Net income: CN¥113.4m (up 45% from 3Q 2020). Profit margin: 13% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 17% per year. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥36.54, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 43% over the past three years. Reported Earnings • Aug 24
Second quarter 2021 earnings released: EPS CN¥0.47 (vs CN¥0.35 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥795.3m (up 38% from 2Q 2020). Net income: CN¥95.9m (up 34% from 2Q 2020). Profit margin: 12% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 13% per year. Tillkännagivande • May 16
Rianlon Corporation Announces Implementation Final Cash Dividend for the Year 2020, Payable on 21 May 2021 Rianlon Corporation announced the implementation of final cash dividend of CNY 2.15000000 per 10 shares (tax included) for the year 2020.
Record date is 20 May 2021 with ex-date on 21 May 2021 and Payment date on 21 May 2021. Net cash dividend/10 shares after tax is CNY 1.93500000. Reported Earnings • Apr 29
First quarter 2021 earnings released: EPS CN¥0.44 (vs CN¥0.31 in 1Q 2020) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: CN¥821.4m (up 46% from 1Q 2020). Net income: CN¥90.4m (up 43% from 1Q 2020). Profit margin: 11% (in line with 1Q 2020). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 23% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Mar 15
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥39.45, the stock trades at a trailing P/E ratio of 27.6x, up from the previous P/E ratio of 23.9x. Average P/E is 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 121%. Tillkännagivande • Mar 10
Rianlon Corporation, Annual General Meeting, Mar 30, 2021 Rianlon Corporation, Annual General Meeting, Mar 30, 2021, at 15:00 China Standard Time. Agenda: To consider the 2020 work report of the board of directors; to consider the 2020 annual accounts; to consider the 2020 annual report and its summary; to consider the 2020 profit distribution plan; to consider the 2021 application for bank credit line; to consider the 2021 remuneration (allowance) for directors; to consider the 2020 work report of the supervisory committee; to consider the 2021 remuneration (allowance) for supervisors; to consider the cash management with proprietary funds by the Company and its subsidiary; and to consider the 2020 special report on the deposit and use of raised funds. Reported Earnings • Mar 09
Full year 2020 earnings released: EPS CN¥1.43 (vs CN¥1.38 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: CN¥2.48b (up 26% from FY 2019). Net income: CN¥293.0m (up 12% from FY 2019). Profit margin: 12% (down from 13% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 20% per year whereas the company’s share price has increased by 25% per year. Analyst Estimate Surprise Post Earnings • Mar 09
Revenue beats expectations, earnings disappoint Revenue exceeded analyst estimates by 5.3%. Earnings per share (EPS) missed analyst estimates by 3.3%. Over the next year, revenue is forecast to grow 15%, compared to a 51% growth forecast for the Chemicals industry in China. Is New 90 Day High Low • Feb 08
New 90-day low: CN¥33.65 The company is down 10.0% from its price of CN¥37.20 on 10 November 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥6.02 per share. Tillkännagivande • Jan 22
Rianlon Corporation to Report Fiscal Year 2020 Results on Mar 09, 2021 Rianlon Corporation announced that they will report fiscal year 2020 results on Mar 09, 2021 Price Target Changed • Dec 26
Price target raised to CN¥43.32 Up from CN¥39.86, the current price target is an average from 6 analysts. The new target price is 11% above the current share price of CN¥39.00. As of last close, the stock is up 8.6% over the past year. Is New 90 Day High Low • Nov 13
New 90-day high: CN¥39.29 The company is up 7.0% from its price of CN¥36.84 on 14 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.83 per share. Price Target Changed • Oct 27
Price target lowered to CN¥38.25 Down from CN¥42.08, the current price target is an average from 6 analysts. The new target price is 10% above the current share price of CN¥34.70. As of last close, the stock is down 7.5% over the past year. Reported Earnings • Oct 26
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥256.7m, down 2.7% from the prior year. Total revenue was CN¥2.28b over the last 12 months, up 27% from the prior year. Tillkännagivande • Oct 16
Rianlon Corporation to Report Q3, 2020 Results on Oct 20, 2020 Rianlon Corporation announced that they will report Q3, 2020 results on Oct 20, 2020 Tillkännagivande • Sep 28
Rianlon Corporation announced that it expects to receive CNY 1 billion in funding Rianlon Corporation (SZSE:300596) announced a private placement of not more than 61,503,126 A shares for gross proceeds of not more than CNY 1,000,000,000 on August 24, 2020. The issue price shall be not less than 80% of the average stock price of the company on the 20 trading days prior to the pricing base date. The transaction will include participation form not more than 35 specific investors. The transaction has been approved at the 15th meeting of the third board of directors of the company. The transaction is still subject to approval from the shareholders in the company’s general shareholder meeting, from Shenzhen Stock Exchange and from China Securities Regulatory Commission. The securities issued in the transaction shall be subject to a hold period of 6 months from the issuance. Tillkännagivande • Aug 06
Rianlon Corporation to Report First Half, 2020 Results on Aug 25, 2020 Rianlon Corporation announced that they will report first half, 2020 results on Aug 25, 2020